The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Earnings for healthcare companies have declined for six straight quarters. But analysts have a more positive outlook going into second quarter earnings.
GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.